Does the media prefer HIMS or FTRE?

In the previous week, Hims & Hers Health had 23 more articles in the media than Fortrea. MarketBeat recorded 24 mentions for Hims & Hers Health and 1 mentions for Fortrea. Hims & Hers Health's average media sentiment score of 0.81 beat Fortrea's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 12 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, PACS or FTRE?

PACS Group has higher revenue and earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.43B 1.09 $191.54M $1.56 23.90 Fortrea $2.71B 0.58 -$986.20M -$4.91 N/A

Is PACS or FTRE more profitable?

PACS Group has a net margin of 4.49% compared to Fortrea's net margin of -16.50%. PACS Group's return on equity of 26.47% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Fortrea -16.50% 9.51% 1.96%

Does the media prefer PACS or FTRE?

In the previous week, PACS Group had 9 more articles in the media than Fortrea. MarketBeat recorded 10 mentions for PACS Group and 1 mentions for Fortrea. Fortrea's average media sentiment score of 0.00 beat PACS Group's score of -0.33 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer FTRE or CAI?

In the previous week, Caris Life Sciences had 2 more articles in the media than Fortrea. MarketBeat recorded 3 mentions for Caris Life Sciences and 1 mentions for Fortrea. Caris Life Sciences' average media sentiment score of 0.38 beat Fortrea's score of 0.00 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Caris Life Sciences 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, FTRE or BLLN?

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fortrea $2.71B 0.58 -$986.20M -$4.91 N/A Billiontoone $354.54M 13.53 $7.45M $0.55 189.60

Does the media refer more to FTRE or BLLN?

In the previous week, Billiontoone had 5 more articles in the media than Fortrea. MarketBeat recorded 6 mentions for Billiontoone and 1 mentions for Fortrea. Fortrea's average media sentiment score of 0.00 beat Billiontoone's score of -0.18 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Billiontoone 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is SHC or FTRE more profitable?

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% Fortrea -16.50% 9.51% 1.96%

Fortrea (FTRE) Competitors

$16.47 +0.91 (+5.85%)

As of 03:57 PM Eastern

Compare

FTRE vs. HIMS, PACS, CAI, BLLN, and SHC

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Fortrea compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Hims & Hers Health presently has a consensus price target of $29.37, suggesting a potential downside of 11.01%. Fortrea has a consensus price target of $17.25, suggesting a potential upside of 4.74%. Given Fortrea's stronger consensus rating and higher probable upside, analysts plainly believe Fortrea is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Hims & Hers Health has a net margin of -0.56% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Fortrea	-16.50%	9.51%	1.96%

In the previous week, Hims & Hers Health had 23 more articles in the media than Fortrea. MarketBeat recorded 24 mentions for Hims & Hers Health and 1 mentions for Fortrea. Hims & Hers Health's average media sentiment score of 0.81 beat Fortrea's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hims & Hers Health has higher earnings, but lower revenue than Fortrea. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.25	$128.37M	-$0.09	N/A
Fortrea	$2.71B	0.58	-$986.20M	-$4.91	N/A

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, indicating that its stock price is 112% more volatile than the broader market.

Summary

Hims & Hers Health beats Fortrea on 9 of the 16 factors compared between the two stocks.

How does Fortrea compare to PACS Group?

PACS Group (NYSE:PACS) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

PACS Group presently has a consensus price target of $48.00, suggesting a potential upside of 28.72%. Fortrea has a consensus price target of $17.25, suggesting a potential upside of 4.74%. Given PACS Group's stronger consensus rating and higher possible upside, research analysts plainly believe PACS Group is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

In the previous week, PACS Group had 9 more articles in the media than Fortrea. MarketBeat recorded 10 mentions for PACS Group and 1 mentions for Fortrea. Fortrea's average media sentiment score of 0.00 beat PACS Group's score of -0.33 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has a net margin of 4.49% compared to Fortrea's net margin of -16.50%. PACS Group's return on equity of 26.47% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Fortrea	-16.50%	9.51%	1.96%

PACS Group has higher revenue and earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.43B	1.09	$191.54M	$1.56	23.90
Fortrea	$2.71B	0.58	-$986.20M	-$4.91	N/A

Summary

PACS Group beats Fortrea on 11 of the 12 factors compared between the two stocks.

How does Fortrea compare to Caris Life Sciences?

Fortrea (NASDAQ:FTRE) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

In the previous week, Caris Life Sciences had 2 more articles in the media than Fortrea. MarketBeat recorded 3 mentions for Caris Life Sciences and 1 mentions for Fortrea. Caris Life Sciences' average media sentiment score of 0.38 beat Fortrea's score of 0.00 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Caris Life Sciences has a net margin of 3.75% compared to Fortrea's net margin of -16.50%. Caris Life Sciences' return on equity of 98.28% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Caris Life Sciences	3.75%	98.28%	48.87%

Caris Life Sciences has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.71B	0.58	-$986.20M	-$4.91	N/A
Caris Life Sciences	$348.89M	14.26	-$68.09M	-$7.61	N/A

Fortrea currently has a consensus target price of $17.25, suggesting a potential upside of 4.74%. Caris Life Sciences has a consensus target price of $27.56, suggesting a potential upside of 56.57%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Caris Life Sciences is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

Caris Life Sciences beats Fortrea on 11 of the 13 factors compared between the two stocks.

How does Fortrea compare to Billiontoone?

Fortrea (NASDAQ:FTRE) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Fortrea presently has a consensus target price of $17.25, indicating a potential upside of 4.74%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 20.14%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts clearly believe Billiontoone is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.71B	0.58	-$986.20M	-$4.91	N/A
Billiontoone	$354.54M	13.53	$7.45M	$0.55	189.60

In the previous week, Billiontoone had 5 more articles in the media than Fortrea. MarketBeat recorded 6 mentions for Billiontoone and 1 mentions for Fortrea. Fortrea's average media sentiment score of 0.00 beat Billiontoone's score of -0.18 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Billiontoone	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Billiontoone	N/A	N/A	N/A

Summary

Billiontoone beats Fortrea on 9 of the 13 factors compared between the two stocks.

How does Fortrea compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Sotera Health has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market.

Sotera Health has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.88	$77.94M	$0.41	38.63
Fortrea	$2.71B	0.58	-$986.20M	-$4.91	N/A

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 0.7% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Fortrea had 1 more articles in the media than Sotera Health. MarketBeat recorded 1 mentions for Fortrea and 0 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.00 equaled Fortrea'saverage media sentiment score.

Company	Overall Sentiment
Sotera Health	Neutral
Fortrea	Neutral

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Fortrea	-16.50%	9.51%	1.96%

Sotera Health currently has a consensus price target of $20.29, indicating a potential upside of 28.07%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 4.74%. Given Sotera Health's stronger consensus rating and higher possible upside, research analysts clearly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Sotera Health beats Fortrea on 12 of the 15 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.56B	$3.45B	$6.46B	$12.11B
Dividend Yield	N/A	2.32%	2.68%	5.81%
P/E Ratio	-3.35	20.09	24.71	24.00
Price / Sales	0.58	188.30	492.47	90.40
Price / Cash	1.54	56.54	27.92	37.84
Price / Book	2.70	8.28	10.82	6.53
Net Income	-$986.20M	$23.85M	$3.56B	$336.99M
7 Day Performance	3.07%	5.21%	1.67%	-0.22%
1 Month Performance	24.58%	2.19%	0.43%	0.77%
1 Year Performance	222.94%	60.99%	32.84%	31.57%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	2.3109 of 5 stars	$16.47 +5.8%	$17.25 +4.7%	+192.5%	$1.56B	$2.71B	N/A	14,300
HIMS Hims & Hers Health	3.1041 of 5 stars	$30.10 +12.2%	$28.70 -4.6%	-47.9%	$6.21B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down
PACS PACS Group	3.7959 of 5 stars	$36.23 -0.2%	$48.00 +32.5%	+185.2%	$5.74B	$5.29B	23.22	47,455	News Coverage Insider Trade
CAI Caris Life Sciences	4.4184 of 5 stars	$18.18 +1.2%	$27.56 +51.6%	N/A	$5.08B	$812.03M	N/A	1,846
BLLN Billiontoone	3.418 of 5 stars	$103.95 +2.8%	$125.29 +20.5%	N/A	$4.65B	$305.11M	189.00	620	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. HIMS, PACS, CAI, BLLN, and SHC

How does Fortrea compare to Hims & Hers Health?

Summary

How does Fortrea compare to PACS Group?

Summary

How does Fortrea compare to Caris Life Sciences?

Summary

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. HIMS, PACS, CAI, BLLN, and SHC

How does Fortrea compare to Hims & Hers Health?

Do analysts recommend HIMS or FTRE?

Is HIMS or FTRE more profitable?

Does the media prefer HIMS or FTRE?

Which has higher valuation and earnings, HIMS or FTRE?

Do insiders and institutionals hold more shares of HIMS or FTRE?

Which has more volatility and risk, HIMS or FTRE?

Summary

How does Fortrea compare to PACS Group?

Do analysts prefer PACS or FTRE?

Does the media prefer PACS or FTRE?

Is PACS or FTRE more profitable?

Which has better valuation & earnings, PACS or FTRE?

Summary

How does Fortrea compare to Caris Life Sciences?

Does the media prefer FTRE or CAI?

Is FTRE or CAI more profitable?

Which has higher earnings and valuation, FTRE or CAI?

Do analysts rate FTRE or CAI?

Summary

How does Fortrea compare to Billiontoone?

Do analysts rate FTRE or BLLN?

Which has preferable valuation & earnings, FTRE or BLLN?

Does the media refer more to FTRE or BLLN?

Is FTRE or BLLN more profitable?

Summary

How does Fortrea compare to Sotera Health?

Which has more risk and volatility, SHC or FTRE?

Which has better valuation and earnings, SHC or FTRE?

Do insiders & institutionals believe in SHC or FTRE?

Does the media prefer SHC or FTRE?

Is SHC or FTRE more profitable?

Do analysts rate SHC or FTRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools